- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
-
- 长期趋势：
已有38家主力机构披露2024-12-31报告期持股数据，持仓量总计9497.69万股，占流通A股25.55%
- 波段诊断：
-
技术面诊股
平均成本
近期的平均成本为15.58元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"15.58","date":1748333287,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，明显跑输行业平均水平。
[{"date":"2025.05.28","stock":"-1.65","trade":"-0.87","ind":"-0.26"},{"date":"2025.05.27","stock":"2.61","trade":"1.70","ind":"-0.61"},{"date":"2025.05.26","stock":"-1.54","trade":"-1.54","ind":"-0.41"},{"date":"2025.05.23","stock":"-1.33","trade":"1.48","ind":"-0.85"},{"date":"2025.05.22","stock":"-3.78","trade":"-0.63","ind":"-0.72"},{"date":"2025.05.21","stock":"-1.21","trade":"0.98","ind":"0.44"},{"date":"2025.05.20","stock":"4.41","trade":"2.06","ind":"0.77"},{"date":"2025.05.19","stock":"-4.51","trade":"-0.40","ind":"-0.08"},{"date":"2025.05.16","stock":"-3.48","trade":"2.01","ind":"-0.07"},{"date":"2025.05.15","stock":"2.07","trade":"1.24","ind":"-1.62"},{"date":"2025.05.14","stock":"0.12","trade":"-0.18","ind":"0.64"},{"date":"2025.05.13","stock":"1.43","trade":"0.62","ind":"-0.13"},{"date":"2025.05.12","stock":"-1.47","trade":"-0.38","ind":"1.72"},{"date":"2025.05.09","stock":"-1.33","trade":"-0.52","ind":"-0.69"},{"date":"2025.05.08","stock":"0.82","trade":"0.35","ind":"0.93"},{"date":"2025.05.07","stock":"-0.29","trade":"0.10","ind":"0.22"},{"date":"2025.05.06","stock":"9.36","trade":"1.78","ind":"1.84"},{"date":"2025.04.30","stock":"2.61","trade":"0.63","ind":"0.51"},{"date":"2025.04.29","stock":"-2.11","trade":"0.18","ind":"-0.05"},{"date":"2025.04.28","stock":"-4.23","trade":"-1.55","ind":"-0.62"},{"date":"2025.04.25","stock":"-3.32","trade":"-1.82","ind":"0.39"}]
金城医药,深证成指,化学制药指数
压力支撑
该股压力位为15.60元，支撑位为15.36元。
[{"text":"\u538b\u529b\u4f4d","value":"15.60","date":1748361600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"15.36","date":1748361600,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.0资金面打败了9%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：05月28日 20:30
| 机构今日流向(万元) | -1493.29 | 机构5日流向(万元) | -4006.03 |
| 机构10日流向(万元) | -4319.35 | 机构20日流向(万元) | -10175.40 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量减少793.55万股，其中基金净增仓5家，主力净减仓75家，暂未发现中长期投资价值。
截止2024-12-31，共38家主力机构（基金34家，一般法人4家），持仓量总计9497.69万股，占流通A股25.55%
其中，基金持仓与2024-06-30相比：
增仓：8家 ，增持 28.17万股
减仓：3家 ，减持 4.76万股
新出现在主力名单中：20家 ，持有396.95万股
从主力名单中消失：95家 ，原持有1204.47万股
其中，基金持仓与2024-06-30相比：
增仓：8家 ，增持 28.17万股
减仓：3家 ，减持 4.76万股
新出现在主力名单中：20家 ，持有396.95万股
从主力名单中消失：95家 ，原持有1204.47万股
消息面诊股
诊断结果：6.6消息面打败了78%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 金城医药：5月27日获融资买入4434.34万元，
2025-05-28 - 金城医药：子公司金城生物作为宠物制剂的原料供应商
2025-05-28 - 本周医药板块上涨 1.78%，诺诚健华坦昔妥单抗获
2025-05-28 - 金城医药：不存在逾期对外担保
2025-05-27 - 金城医药：公司2024年度利润分配工作已于2025
2025-05-27 - 长城证券*行业报告*本周医药板块上涨1.78%，诺
2025-05-27 - 金城医药：5月26日获融资买入2501.37万元
2025-05-27 - 金城医药：5月23日获融资买入2808.68万元
2025-05-26 - “麦角硫因”概念火热！多家上市公司回应
2025-05-23 - 金城医药：5月22日获融资买入3237.59万元
2025-05-23
消息列表
| 一般消息 | 股东大会 | 年度股东大会 | 2025-03-28 |
| 利好 | 分红转增 | 10派1.5元(含税) | 2025-03-28 |
| 利好 | 分红转增 | 10派1.5元(含税) | 2025-01-18 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 利好 | 分红转增 | 10派1元(含税) | 2024-08-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-07-24 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-07-15 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-06-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 5条 | 0条 | 5条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：8.0行业面打败了98%的股票
化学制药行业最新资金流向
近10日来该行业走势明显向上，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，明显跑赢大盘。
[{"date":"2025.05.28","price":"-0.26","value":"-0.87"},{"date":"2025.05.27","price":"-0.61","value":"1.70"},{"date":"2025.05.26","price":"-0.41","value":"-1.54"},{"date":"2025.05.23","price":"-0.85","value":"1.48"},{"date":"2025.05.22","price":"-0.72","value":"-0.63"},{"date":"2025.05.21","price":"0.44","value":"0.98"},{"date":"2025.05.20","price":"0.77","value":"2.06"},{"date":"2025.05.19","price":"-0.08","value":"-0.40"},{"date":"2025.05.16","price":"-0.07","value":"2.01"},{"date":"2025.05.15","price":"-1.62","value":"1.24"},{"date":"2025.05.14","price":"0.64","value":"-0.18"},{"date":"2025.05.13","price":"-0.13","value":"0.62"},{"date":"2025.05.12","price":"1.72","value":"-0.38"},{"date":"2025.05.09","price":"-0.69","value":"-0.52"},{"date":"2025.05.08","price":"0.93","value":"0.35"},{"date":"2025.05.07","price":"0.22","value":"0.10"},{"date":"2025.05.06","price":"1.84","value":"1.78"},{"date":"2025.04.30","price":"0.51","value":"0.63"},{"date":"2025.04.29","price":"-0.05","value":"0.18"},{"date":"2025.04.28","price":"-0.62","value":"-1.55"},{"date":"2025.04.25","price":"0.39","value":"-1.82"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 汉商集团 | 202.51% | 1.56% | 5.4分 |
| 2 | 能特科技 | 173.50% | 1.27% | 5.7分 |
| 3 | 永安药业 | 107.85% | 46.35% | 5.2分 |
| 4 | *ST赛隆 | 85.11% | 27.68% | 4.5分 |
| 5 | 奥锐特 | 82.05% | -1.14% | 5.2分 |
| 6 | 上海谊众 | 66.53% | -0.24% | 4.8分 |
| 8 | 常山药业 | 55.10% | 18.75% | 5.6分 |
| 10 | 百济神州 | 37.48% | -8.17% | 5.2分 |
| 12 | 泰恩康 | 33.00% | 6.45% | 5.0分 |
| 14 | 海翔药业 | 28.92% | 21.36% | 5.5分 |
| 16 | 新天地 | 26.40% | 15.08% | 5.2分 |
| 18 | 一品红 | 24.06% | -7.06% | 4.7分 |
| 20 | 拓新药业 | 21.89% | -18.12% | 4.3分 |
| 22 | 金石亚药 | 19.64% | 2.45% | 5.0分 |
| 24 | 键凯科技 | 17.63% | 7.76% | 5.8分 |
| 26 | 新诺威 | 16.14% | 4.85% | 5.4分 |
| 28 | 民生健康 | 15.42% | 5.49% | 5.4分 |
| 30 | 莎普爱思 | 14.02% | -1.08% | 5.3分 |
| 32 | 华东医药 | 13.05% | 1.02% | 5.6分 |
| 34 | 益方生物 | 12.37% | 3.24% | 5.5分 |
| 36 | 振东制药 | 11.84% | 7.25% | 5.2分 |
| 38 | 共同药业 | 10.89% | -1.33% | 4.9分 |
| 40 | 博瑞医药 | 10.39% | -2.49% | 4.3分 |
| 42 | 信立泰 | 9.48% | 1.42% | 5.5分 |
| 44 | 誉衡药业 | 9.27% | 9.27% | 5.1分 |
| 46 | 恒瑞医药 | 8.35% | -2.67% | 6.1分 |
| 48 | 首药控股 | 8.22% | -3.44% | 4.5分 |
| 50 | 亨迪药业 | 8.07% | -1.71% | 4.2分 |
| 52 | 西点药业 | 7.91% | 1.75% | 4.7分 |
| 54 | 力生制药 | 7.80% | 1.78% | 5.6分 |
| 56 | 富祥药业 | 7.64% | 4.88% | 4.5分 |
| 58 | 人福医药 | 7.46% | 5.79% | 6.2分 |
| 60 | 山河药辅 | 6.82% | 1.58% | 5.0分 |
| 62 | 海南海药 | 6.48% | -11.74% | 4.4分 |
| 64 | 奥翔药业 | 6.35% | 0.00% | 5.5分 |
| 66 | 吉贝尔 | 6.05% | 2.24% | 5.4分 |
| 68 | 莱美药业 | 5.74% | -2.51% | 4.7分 |
| 70 | 华润双鹤 | 4.90% | -1.55% | 5.1分 |
| 72 | 丰原药业 | 4.82% | -0.81% | 5.6分 |
| 74 | 诚意药业 | 4.76% | -2.17% | 5.4分 |
| 76 | 同和药业 | 4.25% | -0.94% | 4.4分 |
| 78 | 华仁药业 | 3.97% | -1.26% | 4.7分 |
| 80 | 恩华药业 | 3.79% | 4.78% | 5.6分 |
| 82 | 中关村 | 3.48% | -1.17% | 5.5分 |
| 84 | 本立科技 | 3.37% | -3.66% | 4.2分 |
| 86 | 津药药业 | 3.23% | -0.48% | 5.4分 |
| 88 | 福元医药 | 3.14% | -1.41% | 5.4分 |
| 90 | 联环药业 | 3.00% | -1.17% | 5.1分 |
| 92 | 丽珠集团 | 2.86% | 0.62% | 5.1分 |
| 94 | 北大医药 | 2.67% | -2.53% | 5.0分 |
| 96 | 普洛药业 | 2.56% | -0.80% | 4.9分 |
| 98 | 前沿生物 | 2.35% | -1.13% | 4.9分 |
| 100 | 海正药业 | 2.16% | -0.77% | 5.6分 |
| 102 | 双鹭药业 | 1.98% | -1.61% | 4.4分 |
| 104 | 国药现代 | 1.55% | -0.38% | 5.6分 |
| 106 | 润都股份 | 0.73% | -9.92% | 4.1分 |
| 108 | 新和成 | 0.60% | -2.76% | 4.8分 |
| 110 | 溢多利 | 0.39% | -1.53% | 4.2分 |
| 112 | *ST三圣 | 0.24% | -4.30% | 4.2分 |
| 114 | 鲁抗医药 | -0.19% | -2.08% | 4.6分 |
| 116 | 福安药业 | -0.24% | -1.45% | 4.7分 |
| 118 | 华北制药 | -1.01% | -3.28% | 4.8分 |
| 120 | - | -1.32% | 0.27% | 分 |
| 122 | 罗欣药业 | -2.86% | -0.45% | 4.5分 |
| 124 | 天新药业 | -3.13% | 0.41% | 5.3分 |
| 126 | 花园生物 | -3.43% | -4.44% | 4.1分 |
| 128 | 东诚药业 | -4.19% | -2.18% | 4.7分 |
| 130 | 健友股份 | -4.48% | -1.81% | 5.1分 |
| 132 | 东北制药 | -5.68% | -2.28% | 4.8分 |
| 134 | 盟科药业 | -5.70% | -10.92% | 4.0分 |
| 136 | 九典制药 | -6.13% | -3.38% | 4.3分 |
| 138 | 纳微科技 | -7.69% | -4.40% | 4.7分 |
| 140 | *ST景峰 | -9.84% | 4.27% | 5.2分 |
| 142 | 诺泰生物 | -10.51% | -11.33% | 4.7分 |
| 144 | 立方制药 | -18.21% | -1.89% | 5.3分 |
| 146 | *ST苏吴 | -36.22% | 4.48% | 5.8分 |
| 148 | 汇宇制药 | -61.87% | 1.23% | 5.8分 |
| 150 | 悦康药业 | - | -5.56% | 3.9分 |
| 152 | 广济药业 | - | -2.14% | 4.7分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
诊断结果：6.0基本面打败了52%的股票
连续3年业绩增长30%的公司
该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。
[ 截止日期：2025-03-31 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 86/227 ， 107/227。
[{"date":"2025-03-31","value":"0.93","vol":"-0.17"},{"date":"2024-12-31","value":"5.26","vol":"19.44"},{"date":"2024-09-30","value":"4.07","vol":"4.58"},{"date":"2024-06-30","value":"3.51","vol":"3.53"},{"date":"2024-03-31","value":"2.22","vol":"2.30"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.93 | 5.26 | 4.07 | 3.51 | 2.22 |
| 行业(%) | -0.17 | 19.44 | 4.58 | 3.53 | 2.30 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"34.17","vol":"49.23"},{"date":"2024-12-31","value":"40.13","vol":"51.10"},{"date":"2024-09-30","value":"40.13","vol":"50.51"},{"date":"2024-06-30","value":"40.62","vol":"50.84"},{"date":"2024-03-31","value":"44.50","vol":"50.75"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
34.17 | 40.13 | 40.13 | 40.62 | 44.50 |
| 行业(%) | 49.23 | 51.10 | 50.51 | 50.84 | 50.75 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 124/227 ， 118/227。
[{"date":"2025-03-31","value":"-22.52","vol":"-0.86"},{"date":"2024-12-31","value":"-4.66","vol":"17.58"},{"date":"2024-09-30","value":"-2.08","vol":"45.26"},{"date":"2024-06-30","value":"3.12","vol":"705.46"},{"date":"2024-03-31","value":"12.32","vol":"744.46"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-22.52 | -4.66 | -2.08 | 3.12 | 12.32 |
| 行业(%) | -0.86 | 17.58 | 45.26 | 705.46 | 744.46 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"-57.75","vol":"-21.71"},{"date":"2024-12-31","value":"12.63","vol":"-40.60"},{"date":"2024-09-30","value":"14.02","vol":"-0.63"},{"date":"2024-06-30","value":"28.40","vol":"8.83"},{"date":"2024-03-31","value":"65.43","vol":"18.72"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-57.75 | 12.63 | 14.02 | 28.40 | 65.43 |
| 行业(%) | -21.71 | -40.60 | -0.63 | 8.83 | 18.72 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 36/227 ， 36/227。
[{"date":"2025-03-31","value":"0.13","vol":"0.10"},{"date":"2024-12-31","value":"0.59","vol":"0.43"},{"date":"2024-09-30","value":"0.44","vol":"0.33"},{"date":"2024-06-30","value":"0.30","vol":"0.23"},{"date":"2024-03-31","value":"0.16","vol":"0.12"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.13 | 0.59 | 0.44 | 0.30 | 0.16 |
| 行业(次) | 0.10 | 0.43 | 0.33 | 0.23 | 0.12 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.80","vol":"0.67"},{"date":"2024-12-31","value":"3.67","vol":"3.23"},{"date":"2024-09-30","value":"2.73","vol":"2.17"},{"date":"2024-06-30","value":"2.00","vol":"1.51"},{"date":"2024-03-31","value":"1.00","vol":"0.74"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.80 | 3.67 | 2.73 | 2.00 | 1.00 |
| 行业(次) | 0.67 | 3.23 | 2.17 | 1.51 | 0.74 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-03-31","value":"-1.19","vol":"-28.86"},{"date":"2024-12-31","value":"11.09","vol":"-368.97"},{"date":"2024-09-30","value":"3.50","vol":"-9.88"},{"date":"2024-06-30","value":"16.15","vol":"-252.28"},{"date":"2024-03-31","value":"4.44","vol":"-3.76"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -1.19 | 11.09 | 3.50 | 16.15 | 4.44 |
| 行业 | -28.86 | -368.97 | -9.88 | -252.28 | -3.76 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.44","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.48","vol":"2.19"},{"date":"2024-03-31","value":"","vol":"0.00"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.44 | - | 0.48 | - |
| 行业 | 0.00 | 2.00 | 0.00 | 2.19 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 7/227 ， 44/227。
[{"date":"2025-03-31","value":"1.95","vol":"3.59"},{"date":"2024-12-31","value":"1.83","vol":"3.32"},{"date":"2024-09-30","value":"1.65","vol":"3.67"},{"date":"2024-06-30","value":"1.61","vol":"3.60"},{"date":"2024-03-31","value":"1.57","vol":"3.71"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
1.95 | 1.83 | 1.65 | 1.61 | 1.57 |
| 行业 | 3.59 | 3.32 | 3.67 | 3.60 | 3.71 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"1.38","vol":"2.81"},{"date":"2024-12-31","value":"1.32","vol":"2.62"},{"date":"2024-09-30","value":"1.17","vol":"2.92"},{"date":"2024-06-30","value":"1.21","vol":"2.89"},{"date":"2024-03-31","value":"1.19","vol":"3.06"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
1.38 | 1.32 | 1.17 | 1.21 | 1.19 |
| 行业 | 2.81 | 2.62 | 2.92 | 2.89 | 3.06 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 69/227 ， 75/227。
[{"date":"2025-03-31","value":"30.30","vol":"33.96"},{"date":"2024-12-31","value":"31.63","vol":"34.28"},{"date":"2024-09-30","value":"32.87","vol":"32.89"},{"date":"2024-06-30","value":"33.85","vol":"33.06"},{"date":"2024-03-31","value":"35.28","vol":"32.53"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
30.30 | 31.63 | 32.87 | 33.85 | 35.28 |
| 行业(%) | 33.96 | 34.28 | 32.89 | 33.06 | 32.53 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.44","vol":"1.46"},{"date":"2024-12-31","value":"0.47","vol":"0.84"},{"date":"2024-09-30","value":"0.50","vol":"0.72"},{"date":"2024-06-30","value":"0.52","vol":"0.70"},{"date":"2024-03-31","value":"0.56","vol":"0.69"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.44 | 0.47 | 0.50 | 0.52 | 0.56 |
| 行业(%) | 1.46 | 0.84 | 0.72 | 0.70 | 0.69 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"1.08","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"2.73","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.75","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.97","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]